Toni K. Choueiri, MD

Articles by Toni K. Choueiri, MD

Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC

June 15th 2026

Toni K. Choueiri, MD, discusses the FDA approval of adjuvant belzutifan plus pembrolizumab for clear cell renal cell carcinoma, describing the regimen as a major advancement in kidney cancer treatment.

Toni Choueiri, MD, on key takeaways from LITESPARK-022 in ccRCC

ByToni K. Choueiri, MD

February 28th 2026

Toni K. Choueiri, MD, discusses the background and key findings from the phase 3 LITESPARK-022 trial.

Toni K. Choueiri, MD

Articles by Toni K. Choueiri, MD

Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC

Toni Choueiri, MD, on key takeaways from LITESPARK-022 in ccRCC

Latest Updated Articles

Trending on Urology Times

The ArteraAI Prostate Test: What It Is and How It Works

HHS requests testosterone therapy label updates, citing new safety data

Retrospective study suggests differences in OAB therapy persistence among older adults

FDA gives nod to feasibility study of NanoKnife IRE for benign prostatic hyperplasia

Unmet needs and emerging solutions in MRI-guided prostate cancer care